Skip to contentClarengateINTELLIGENCE
Companies/09552057

Gemini Biosciences Ltd

Private Limited Company · Royal Victoria Docks

Creditors Voluntary Liquidation (CVL)United KingdomIncorporated 2015Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2024-09-30

IXBRL · 50 source facts · 14 selected values

Not assessed
legacy record
Reporting period
2023-10-01 to 2024-09-30
Extraction status
Legacy / not assessed
Numeric facts
20
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_3000_09552057_20240930
Source archive
Accounts_Monthly_Data-October2024.zip

Accounts to 2023-09-30

IXBRL · 51 source facts · 14 selected values

Not assessed
legacy record
Reporting period
2022-10-01 to 2023-09-30
Extraction status
Legacy / not assessed
Numeric facts
20
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_1866_09552057_20230930
Source archive
Accounts_Monthly_Data-March2024.zip

Accounts to 2022-09-30

IXBRL · 49 source facts · 14 selected values

Not assessed
legacy record
Reporting period
2021-10-01 to 2022-09-30
Extraction status
Legacy / not assessed
Numeric facts
20
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_0018_09552057_20220930
Source archive
Accounts_Monthly_Data-June2023.zip

Accounts to 2021-09-30

IXBRL · 51 source facts · 14 selected values

Not assessed
legacy record
Reporting period
2020-10-01 to 2021-09-30
Extraction status
Legacy / not assessed
Numeric facts
18
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_0102_09552057_20210930
Source archive
Accounts_Monthly_Data-February2022.zip

Accounts to 2020-09-30

IXBRL · 51 source facts · 14 selected values

Not assessed
legacy record
Reporting period
2019-10-01 to 2020-09-30
Extraction status
Legacy / not assessed
Numeric facts
18
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0091_09552057_20200930
Source archive
Accounts_Monthly_Data-June2021.zip

Accounts to 2019-09-30

IXBRL · 50 source facts · 12 selected values

Not assessed
legacy record
Reporting period
2018-10-01 to 2019-09-30
Extraction status
Legacy / not assessed
Numeric facts
16
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0073_09552057_20190930
Source archive
Accounts_Monthly_Data-December2019.zip

Accounts to 2018-09-30

IXBRL · 50 source facts · 12 selected values

Not assessed
legacy record
Reporting period
2017-10-01 to 2018-09-30
Extraction status
Legacy / not assessed
Numeric facts
16
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0063_09552057_20180930
Source archive
Accounts_Monthly_Data-February2019.zip

Accounts to 2017-09-30

IXBRL · 54 source facts · 12 selected values

Not assessed
legacy record
Reporting period
2016-10-01 to 2017-09-30
Extraction status
Legacy / not assessed
Numeric facts
16
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0051_09552057_20170930
Source archive
Accounts_Monthly_Data-February2018.zip

Accounts to 2016-09-30

IXBRL · 47 source facts · 6 selected values

Not assessed
legacy record
Reporting period
2015-04-21 to 2016-09-30
Extraction status
Legacy / not assessed
Numeric facts
8
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0038_09552057_20160930
Source archive
Accounts_Monthly_Data-January2017.zip

Registered details

09552057
Status
Liquidation
Type
Private Limited Company
Incorporated
2015-04-21
Jurisdiction
—
Registered office
WAREHOUSE W, 3 WESTERN GATEWAY, ROYAL VICTORIA DOCKS, LONDON, E16 1BD

Classification

1 SIC codes
23009

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

2 matched grants
Identifying biomarkers of treatment response in gestational trophoblastic disease through quantitative proteomics analysis of patient samples
MRC · Studentship · 2019-11-01 – 2023-07-30 · with 1 other participant
£0
whole project
Imperial College LondonleadGemini BioSciences Ltd
Centre for Drug Safety Science (CDSS)
MRC · Research Grant · 2014-03-01 – 2022-12-31 · with 54 other participants
£3,072,999
whole project
University of LiverpoolleadAcademy of FinlandAllecra Therapeutics SASAmgen IncAndalusian Health ServiceASLAN PharmaceuticalsAstex PharmaceuticalsAstrazenecaBio.logis Genetic Information Management GMBHDiabetes UKEli Lilly & Company LtdF. Hoffmann-La Roche AGGemini Biosciences Ltd.GlaxoSmithKline (GSK)Illumina Inc.Imperial College LondonKarolinska InstituteKNMP Holding B.V.Leiden University Medical CenterLgc LtdLiverpool Health PartnersLiverpool Heart And Chest Hospital NHS Foundation TrustMC DiagnosticsMcLaren Applied TechnologiesMedical Research Council (MRC)Medical University of ViennaMedicines for Malaria Venture (MMV)MerckNewcastle UniversityNovartisNovartis Institutes for BioMedical Research (NIBR)Oncological Referral CentreOtsuka PharmaceuticalPaul Sabatier University (University of Toulouse III)Pfizer IncRobert Bosch FoundationRoyal Brompton & Harefield NHS Foundation TrustRoyal Liverpool and Broadgreen University Hospitals NHS TrustRoyal Liverpool University HospitalSengenicsSt Antonius HospitalSysmex CorporationThe Federal Institute for Drugs and Medical DevicesThe Golden Helix FoundationUcb SAUniversity College LondonUniversity Of BirminghamUniversity of British ColumbiaUniversity of CambridgeUniversity of LeicesterUniversity of LjubljanaUniversity Of ManchesterUniversity Of OxfordUniversity of PatrasUppsala University